273 related articles for article (PubMed ID: 23022254)
1. Unique prognostic factors in acral lentiginous melanoma.
Egger ME; McMasters KM; Callender GG; Quillo AR; Martin RC; Stromberg AJ; Scoggins CR
Am J Surg; 2012 Dec; 204(6):874-9; discussion 879-80. PubMed ID: 23022254
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and survival differences between upper and lower extremity melanomas.
Egger ME; Tabler BL; Dunki-Jacobs EM; Callender GG; Scoggins CR; Martin RC; Quillo AR; Stromberg AJ; McMasters KM
Am Surg; 2012 Jul; 78(7):779-87. PubMed ID: 22748538
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and prognostic factors in nodular melanomas.
Egger ME; Dunki-Jacobs EM; Callender GG; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM
Surgery; 2012 Oct; 152(4):652-9; discussion 659-60. PubMed ID: 22925134
[TBL] [Abstract][Full Text] [Related]
5. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
6. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
7. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
Chagpar RB; Ross MI; Reintgen DS; Edwards MJ; Scoggins CR; Martin RC; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; McMasters KM
J Surg Res; 2007 Nov; 143(1):164-8. PubMed ID: 17950088
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
10. Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
Egger ME; Huber KM; Dunki-Jacobs EM; Quillo AR; Scoggins CR; Martin RC; Stromberg AJ; McMasters KM; Callender GG
J Am Coll Surg; 2013 Jul; 217(1):37-44; discussion 44-5. PubMed ID: 23791271
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
13. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion as a prognostic factor in melanoma.
Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
White I; Fortino J; Curti B; Vetto J
Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
20. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
Fujisawa Y; Otsuka F;
Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
